10 Best Healthcare Stocks to Buy and Hold for 3 Years
The first quarter of this year has seen a great deal of volatility in the equity markets. The S&P 500 fell into correction territory before rising again after first soaring to all-time highs.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 23,299 | $21,429,447 | -1% | 3.71% |
| 2. | Ayrshire Capital Management John Nevin Jr. | 6,706 | $6,168,029 | -31% | 3.19% |
| 3. | Bayforest Capital Theodoros Tsagaris | 87 | $80,020 | 0.09% | |
| 4. | Sivik Global Healthcare Krishen Sud | 5,000 | $4,599 | -29% | 3.49% |
| 5. | Syquant Capital Olivier Leymarie And Henri Jeantet | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $691.79 | 715 | $494,626.99 | 14,685 | 2025-08-15 | Filing | |
| $660.25 | 758 | $500,472.53 | 758 | 2025-08-13 | Filing | |
| $647.36 | 1,000 | $647,360.00 | 20,562 | 2025-08-13 | Filing | |
| $644.77 | 1,632 | $1,052,263.01 | 546,601 | 2025-08-12 | Filing | |
| $634.41 | 1,000 | $634,405.00 | 137,660 | 2025-08-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1,116.69 | 2,737 | $3,056,369.58 | 91,896,978 | 2026-01-07 | Filing | |
| $1,115.76 | 2,210 | $2,465,831.81 | 91,899,715 | 2026-01-07 | Filing | |
| $1,114.37 | 4,342 | $4,838,603.22 | 91,901,925 | 2026-01-07 | Filing | |
| $1,113.77 | 9,053 | $10,082,968.86 | 91,906,267 | 2026-01-07 | Filing | |
| $1,112.43 | 4,652 | $5,175,038.32 | 91,915,320 | 2026-01-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,444,355 | $1,326,868,680 | 20.02% | |
| 2. | 540,417 | $497,059,392 | 24.04% | |
| 3. | 265,844 | $244,515,352 | 3.01% | |
| 4. | 215,812 | $198,497,403 | 1.3% | |
| 5. | 166,613 | $153,245,638 | 1.88% |
News See All
Guggenheim Remains Bullish on Eli Lilly (LLY) Ahead of Q1 2026 Results
On March 30, 2026, Guggenheim updated its model ahead of the first-quarter data and lowered the firm’s price target for Eli Lilly and Company (NYSE:LLY) from $1,168 to $1,163, while keeping a “Buy...
Jim Cramer Discussed The Iran Ceasefire & Commented On These 19 Stocks
In this article, we will discuss: Jim Cramer Discussed The Iran Ceasefire & Commented On These 19 Stocks.
14 Hedge Fund Favorites with Strong Setup in 2026
As of March 30, 2026, the case for hedge fund favorites with a good setup in 2026 is being shaped by how institutional investors are positioned relative to policy changes, inflationary concerns, and sector...
15 Best S&P 500 Stocks to Buy Right Now
The S&P 500 posted gains of around 16.4% in 2025.
10 Best Future Stocks to Buy for the Next 5 Years
On March 25, Scott Chronert of Citi joined 'Closing Bell' on CNBC to discuss whether it is time to enter the market and if recent presidential actions have changed the market dynamic.
11 Stocks in Focus: Jim Cramer on NVIDIA, Callers’ Picks, and Recent AI Data Center Rally
In this article, we will look at stocks recently featured on Mad Money, as Jim Cramer analyzed the broader market impact of the recent AI data center rally.
8 Best US Stocks to Buy and Hold for the Next 3 Years
On March 30, Strategas Research Partners chairman & CEO Jason Trennert joined 'Squawk Box' on CNBC to discuss whether escalating geopolitical tensions could derail strong markets and the state of the ...
7 Best Pharma Stocks to Invest In Now
On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.
Eli Lilly and Company (LLY) Continued to Gain from Its Incretin Portfolio
Bristol Gate Capital Partners, an investment management company, published its Q4 2025 investor letter for the “US Equity Strategy”. A copy of the letter can be downloaded here.
Hedge Fund Resource Center